Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

计划入组 10 人 · 首次发布于 2011 年 5 月 9 日

Isotretinoin in Preventing Skin Cancer

首次发布于 2004 年 2 月 27 日

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

首次发布于 2017 年 3 月 3 日

small molecule therapeutic (basal cell carcinoma)

Haemorrhagic Fever with Renal Syndrome Bivalent Vaccine (Vero Cell),Inactivated

renal cell carcinoma program

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Medicus Pharma Seeks Orphan Drug Designation for SkinJect in Rare Gorlin Syndrome

Medicus Pharma Completes Phase 2 Enrollment for Novel Microneedle Basal Cell Carcinoma Treatment

Medicus Pharma Receives UK Regulatory Approval to Expand Phase 2 Basal Cell Carcinoma Study